| Old Articles: <Older 7761-7770 Newer> |
|---|
 |
The Motley Fool
August 5, 2011
Tim Beyers |
Sunrise Senior Living Beaten Down Again: What You Need to Know Shares of Sunrise Senior Living fell more than 10% one day after a 9.8% drop. Investors can't seem to forgive the caregiver for its lousy second-quarter earnings report.   |
The Motley Fool
August 5, 2011
Brian Orelli |
Still Want to Be the Next Dendreon? The biotech market is punished. |
The Motley Fool
August 5, 2011
Rich Smith |
Gentiva Health Services Shares Dropped: What You Need to Know If you thought the worst was over after Gentiva Health Services shed 34% of its market cap yesterday, that would be understandable. Understandable, but wrong. Gentiva is down 13% more today. |
The Motley Fool
August 4, 2011
Seth Jayson |
Here's Why Teva's Latest Report Might Worry You What's going on with the inventory at Teva? I chart the details below for both quarterly and 12-month periods. |
The Motley Fool
August 4, 2011
Sean Williams |
Somaxon's Bore of a Quarter Silenor sales fly out of the gate like molasses in winter. |
The Motley Fool
August 4, 2011
Rex Moore |
Perrigo's Growth May Not Be What It Seems Perrigo has an intangible assets ratio of 40%. |
The Motley Fool
August 4, 2011
Travis Hoium |
Gentiva Health Services Shares Plunged Again: What You Need to Know For the third time this week shares of Gentiva Health Services plunged more than 10%, but unlike Monday and Tuesday, this was a doozy. |
The Motley Fool
August 4, 2011
Brian Orelli |
Pfizer's Long-Shot Lipitor Gamble Don't count on OTC Lipitor anytime soon. |
The Motley Fool
August 4, 2011
Brian Orelli |
Dendreon Down 65%! What's Next? What caused Dendreon's shocking collapse? |
The Motley Fool
August 4, 2011
Arundhati Parmar |
Medtronic Infuse Device Will Be Reviewed by Yale Researchers Medtronic works with Yale on a first-of-its-kind independent review. |
| <Older 7761-7770 Newer> Return to current articles. |
